Biomedical Advanced Research And Development Authority
Description
On March 18, 2026, SPECTRAL AI, INC. announced the award of $31.7 million in funding from the Biomedical Advanced Research and Development Authority (BARDA). This funding aims to accelerate and enhance features of the company's DeepView® System, an innovative AI technology for treating burn wounds.
Company Information
Company
Spectral AI
Location
Dallas, Texas, United States
About
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView® System. DeepView® is a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of changing the current standard of care in the future, DeepView® is expected to provide faster and accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs.
Fundz sees it the moment Spectral AI raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
DallasInformation TechnologyBiotechnologyHealth CareArtificial IntelligenceMachine LearningImage Recognition